Key result
Open left adrenalectomy followed by adjuvant paclitaxel in a 61-year-old male with primary adrenal angiosarcoma resulted in metastatic progression at 5 weeks and death 3 months post-surgery.
Why the study?
Primary adrenal angiosarcoma is a rare vascular malignancy with fewer than fifty cases reported in the literature and carries a poor prognosis.
Case Report (n=1)
Primary adrenal angiosarcoma is a rare malignancy with a poor prognosis, as demonstrated by rapid metastatic progression and death within 3 months despite surgical resection and chemotherapy.
Adds rare adrenal angiosarcoma case to sparse literature; leaves open optimal diagnostic and therapeutic strategies.
Primary adrenal angiosarcoma is a rare vascular malignancy with fewer than fifty cases reported in the literature, with a preference for middle-aged men and a poor prognosis with a median survival of around eighteen months and a five-year overall survival of 30 %. A case of a 61-year-old male patient who consulted for pain in the left renal fossa radiating to the ipsilateral flank and constitutional syndrome is reported. Diagnostic imaging tests show a large solid left adrenal mass with no signs of local tumor extension or in other organs; Laboratory studies confirm autoproduction of cortisol and association with probable paraneoplastic consumptive coagulopathy. Open left adrenalectomy was performed with an anatomopathological diagnosis of primary epithelioid angiosarcoma of the adrenal gland and liver metastases. During the immediate postoperative period, hematoma of the surgical site was evidenced, which was treated conservatively with favorable evolution. Subsequently, adjuvant chemotherapy treatment with paclitaxel was administered, presenting metastatic progression in diagnostic imaging tests five weeks after surgery. Exitus letalis, presented three months after surgery.
No takes yet. Share an insight, caveat, or question.
Donoso et al. (2023) conducted a case report in Primary adrenal angiosarcoma (n=1). Open left adrenalectomy and adjuvant chemotherapy with paclitaxel was evaluated on Clinical outcome. Open left adrenalectomy followed by adjuvant paclitaxel in a 61-year-old male with primary adrenal angiosarcoma resulted in metastatic progression at 5 weeks and death 3 months post-surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: